YFLJH GlobalChina Peptide API

2026-07-02

Key Quality, Regulatory, and Documentation Preparation Points Before Auditing Peptide API Suppliers

This article outlines essential quality, regulatory, and documentation considerations for qualified B2B buyers preparing for peptide API supplier audits, emphasizing supplier evaluation, document review, and regulatory compliance.

✓For qualified B2B partners only. Documentation available upon request. Not for personal use or direct consumer sale.

Source references

  1. ICH Q3A(R2) Impurities in New Drug Substances

    International Council for Harmonisation (ICH)

    Guidance on impurity profiling and limits in APIs

  2. FDA Guidance for Industry: Drug Master Files

    U.S. Food and Drug Administration (FDA)

    Regulatory framework for DMF submissions and review

  3. EDQM Certificate of Suitability (CEP) Information

    European Directorate for the Quality of Medicines & HealthCare (EDQM)

    CEP certification process and regulatory acceptance